NCT05184790Recruiting
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
This study will develop a whole-of-body markerless tracking method for measuring the motion of the tumour and surrounding organs during radiation therapy to enable real-time image guidance. Routinely acquired patient data will be used to improve the training, testing and accuracy of a whole-of-body markerless tracking method. When the markerless tracking method is sufficiently advanced, according to the PI of each of the data collection sites, the markerless tracking method will be run in parallel to, but not intervening with, patient treatments during data acquisition.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 22 Dec 2021
- Start date
- 28 Feb 2023
- Primary completion date
- 31 Jan 2028
- Lead sponsor
- University of Sydney
- Diseases
- Prostate cancer, Head and neck cancer, Kidney cancer, Pancreatic cancer, Liver and biliary tract cancer
- NCT number
- NCT05184790
What you commit to
- Study type: Observational
- Planned participants: 300
- From 28 Feb 2023 to the primary completion date, 31 Jan 2028
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Less than 18 years of age
Who the study is looking for
- Will receive radiation therapy for brain, breast, head and neck, kidney, liver, pancreas, prostate, spine cancer treatment or cardiac arrhythmia treatment at a participating centre.
- Will receive CT planning, and a cone beam CT scan for at least one fraction of radiation therapy.
- Will receive intrafraction x-ray imaging for the liver, pancreas, prostate, spine cancer treatment or cardiac arrhythmia treatment. As intrafraction imaging is not common standard of care for brain, breast, head and neck and kidney cancer treatments there is no requirement to have intrafraction x-ray imaging data for these anatomical sites.
- Provides written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peter MacCallum Cancer Centre Coordinator of this site? Confirm its status | Melbourne | Australia | Not yet recruiting |
| Alfred Health Coordinator of this site? Confirm its status | Melbourne | Australia | Not yet recruiting |
| Royal North Shore Hospital Coordinator of this site? Confirm its status | Saint Leonards | Australia | Recruiting |
| Princess Alexandra Hospital Coordinator of this site? Confirm its status | Woolloongabba | Australia | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.